Eric D Shah
Overview
Explore the profile of Eric D Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hennessey M, Xue S, Strigenz R, Bagley P, Shah E
Am J Gastroenterol
. 2025 Feb;
PMID: 39950674
Medical technology in gastroenterology spans devices, point-of-care diagnostics, digital health, and artificial intelligence. We conducted a narrative review of US Food and Drug Administration (FDA)-reviewed medical technology on the available...
2.
Elnaiem A, Hiramoto B, Flanagan R, Muftah M, Shah E, Chan W
Dig Dis Sci
. 2025 Jan;
PMID: 39826063
Background: Chronic constipation, diarrhea, and fecal incontinence (FI) are prevalent with significant impact on quality of life and healthcare utilization. Thyroid dysfunction was recognized as a potential contributor to bowel...
3.
Hiramoto B, Falahee B, Muftah M, Flanagan R, Shah E, Chan W
Clin Transl Gastroenterol
. 2024 Nov;
16(1):e00789.
PMID: 39498983
Introduction: The impact of pelvic bone structure on fecal incontinence (FI) is unclear. We assessed the association between weight-adjusted pelvic area and FI. Methods: This was a population-based analysis of...
4.
Busam J, Shah E
Clin Gastroenterol Hepatol
. 2024 Oct;
23(1):11-13.
PMID: 39419245
No abstract available.
5.
Hiramoto B, Muftah M, Flanagan R, Shah E, Chan W
Am J Gastroenterol
. 2024 Sep;
120(1):161-172.
PMID: 39344968
Introduction: The management strategies for eosinophilic esophagitis include proton pump inhibitors (PPIs), swallowed topical corticosteroids (tCSs), elimination diets, and the biologic agent dupilumab, although there remains little guidance on the...
6.
Amann S, Shah E, Wilson L
Clin Gastroenterol Hepatol
. 2024 Sep;
22(12):2362-2366.
PMID: 39303798
No abstract available.
7.
Shah E, Chey W
Am J Gastroenterol
. 2024 Aug;
119(12):2529-2531.
PMID: 39167526
Introduction: We aimed to evaluate the cost-effectiveness/cost-savings of point-of-care anorectal function testing with an investigational device (RED) to triage therapy for chronic constipation in general gastroenterology. Methods: A Markov model...
8.
Pathipati M, Shah E
Clin Gastroenterol Hepatol
. 2024 Jul;
22(11):2168-2171.
PMID: 39019081
No abstract available.
9.
Wechsler E, Shah E
Clin Gastroenterol Hepatol
. 2024 May;
22(12):2392-2393.
PMID: 38740274
No abstract available.
10.
Hiramoto B, Flanagan R, Muftah M, Shah E, Chan W
Clin Gastroenterol Hepatol
. 2024 Apr;
22(9):1908-1916.e1.
PMID: 38657883
Background And Aims: Fecal incontinence (FI) is highly prevalent with substantial impacts on quality of life and health care utilization. The impact of obesity on FI remains unclear, with differing...